Clinical Trial Update: Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia [Phase 1]

View source ↗

Summary

This Phase 1 study assesses safety, pharmacokinetics and pharmacodynamics of multiple doses of BIWH 3 in patients with chronic critical limb ischemia due to per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Limb-threatening Ischemia
• Peripheral Arterial Disease

Drugs mentioned

• BIWH 3

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Peripheral Arterial Disease | Phase 1 | Status: TERMINATED